EFFICACY OF AZACITIDINE TO RESTORE FULL DONOR CHIMERISM IN MDS OR AML PATIENTS AFTER ALLOGENEIC HSCT: A THERAPEUTIC OPTION FOR TREATMENT OF EARLY RELAPSE

被引：0
|
作者：
Gozzini, A. [1 ]
Guidi, S. [1 ]
Nozzoli, C. [1 ]
Saccardi, R. [1 ]
Santini, V. [2 ]
Donnini, I. [1 ]
Angarano, R. [1 ]
Boncompagni, R. [1 ]
Sanna, A. [1 ]
Bosi, A. [2 ]
机构：
[1] Univ Florence, Hematol, AOU CAREGGI, Florence, Italy
[2] Univ Florence, Hematol, Florence, Italy
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P171
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS
    Radford, Michael
    Garcia-Horton, Alejandro
    Badami, Rohail
    Jin, Elaine
    Usmani, Nida
    Grafodatskaya, Daria
    Mccready, Elizabeth
    Khalaf, Dina
    Walker, Irwin
    Leber, Brian
    Lepic, Kylie
    Pond, Gregory
    Berg, Tobias
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02): : 77e1 - 77e20
  • [22] Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Xu Guo-Fa
    Chen Ting
    Liu Huanfeng
    Lin Shijia
    Lei Gao
    Cheng Zhang
    Yao Liu
    Xi Zhang
    Zeng, Defu
    Kong Peiyan
    BLOOD, 2018, 132
  • [23] Monitoring of Bone Marrow Chimerism after Allogeneic HSCT - Early Relapse Detection by a Quantitative PCR Approach
    Reibke, R.
    Dick, A.
    Hubmann, M.
    Hoster, E.
    Henschler, R.
    Hiddemann, W.
    Spiekermann, K.
    Tischer, J.
    ANNALS OF HEMATOLOGY, 2015, 94 : S99 - S99
  • [24] Chimerism kinetics of unfractionated bone marrow in the first year after allogeneic haematopoietic cell transplantation is predictive of relapse in patients with AML and MDS
    Papalexandri, A.
    Apostolou, C.
    Voutiadou, G.
    Touloumenidou, T.
    Zorbas, I.
    Batsis, I.
    Smias, C.
    Stalika, E.
    Paleta, A.
    Sakellari, I.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S198 - S198
  • [25] Monitoring of Bone Marrow Chimerism after Allogeneic HSCT - Early Relapse Detection by a Quantitative PCR Approach
    Reibke, R.
    Dick, A.
    Hubmann, M.
    Hoster, E.
    Henschler, R.
    Hiddemann, W.
    Spiekermann, K.
    Tischer, J.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 99 - 99
  • [26] Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    de Lima, M
    Carrasco, A
    Lee, MS
    Saliba, R
    Glassman, A
    Anagnostopoulos, A
    Couriel, D
    Caldera, H
    Andersson, BS
    El-Zimaity, M
    Giralt, S
    Champlin, R
    BLOOD, 2003, 102 (11) : 707A - 707A
  • [27] Does fibrosis persist after allogeneic HSCT in patients with myelofibrosis, who are otherwise negative for driver mutations, with full donor chimerism?
    Sora, F.
    Chiusolo, P.
    Laurenti, L.
    Giammarco, S.
    Innocenti, I.
    Metafuni, E.
    Autore, F.
    Galli, E.
    Sica, S.
    Bacigalupo, A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 330 - 330
  • [28] Low-dose azacitidine for relapse of MDS/AML after unrelated donor peripheral blood stem cell transplantation
    Rossetti, James M.
    Shadduck, Richard K.
    Thatikonda, Chandana
    Sahovic, Entezam
    Lister, John
    BLOOD, 2007, 110 (11) : 338B - 338B
  • [29] Chimerism Kinetics of Unfractionated Bone Marrow In the First Year After Allogeneic Hematopoietic Cell Transplantation Is Predictive of Relapse In Patients with AML and MDS.
    Papalexandri, Apostolia
    Apostolou, Chryssa
    Voutiadou, Georgia
    Touloumenidou, Tasoula
    Zorbas, Ioannis
    Batsis, Ioannis
    Smias, Christos
    Stalika, Evangelia
    Paleta, Angeliki
    Sakellari, Ioanna
    Anagnostopoulos, Achilles
    BLOOD, 2010, 116 (21) : 555 - 556
  • [30] Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism
    Beck, JF
    Klingebiel, T
    Kreyenberg, H
    Schaudt, A
    Wölle, W
    Niethammer, D
    Bader, P
    KLINISCHE PADIATRIE, 2002, 214 (04): : 201 - 205
12345